Detalhe da pesquisa
1.
Dupilumab Versus Cyclosporine for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults: Indirect Comparison Using the Eczema Area and Severity Index.
Acta Derm Venereol
; 99(10): 851-857, 2019 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31099402
2.
Disease characteristics, comorbidities, treatment patterns and quality of life impact in children <12 years old with atopic dermatitis: Interim results from the PEDISTAD Real-World Registry.
J Am Acad Dermatol
; 87(5): 1104-1108, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35081419
3.
Evaluation of standard treatments for managing adult Japanese patients with inadequately controlled moderate-to-severe atopic dermatitis: Two-year data from the ADDRESS-J disease registry.
J Dermatol
; 49(9): 903-911, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35715964
4.
Disease burden and treatment history among adults with atopic dermatitis receiving systemic therapy: baseline characteristics of participants on the EUROSTAD prospective observational study.
J Dermatolog Treat
; 32(2): 164-173, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33461356
5.
Protocol for a prospective, observational, longitudinal study in paediatric patients with moderate-to-severe atopic dermatitis (PEDISTAD): study objectives, design and methodology.
BMJ Open
; 10(3): e033507, 2020 03 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32209624
6.
Atopic dermatitis disease registry in Japanese adult patients with moderate to severe atopic dermatitis (ADDRESS-J): Baseline characteristics, treatment history and disease burden.
J Dermatol
; 46(4): 290-300, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30756423